Status:
NOT_YET_RECRUITING
SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a study from Fujian Cancer Hospital Thoracic of Surgery Project, numbered as FJCHTOSP-1. Systematically mediastinal Lymph Node Dissection (SLD) Versus Non-Dissection Following Endoscopic Submu...
Detailed Description
Participants will be evaluated for inclusion criteria and exclusion criteria, and then sign informal consent if desired. Participants will be randomly assigned to the intervention according to a prepa...
Eligibility Criteria
Inclusion
- Clinical stage T1aN0M0.
- A lesion detected on Endoscopic Ultrasound featured as T1a stage.
- Age 18 to 75.
- Patients who have signed the informed consent form.
Exclusion
- • Other than invasive adenocarcinoma by pathological analysis.
- Not complete resected or curative intent.
- Patients who have history of other malignant tumors.
- Patients who have history of thoracic surgery.
- Patients who have received radiation, chemotherapy or other treatments previously.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06979986
Start Date
June 1 2025
End Date
April 1 2027
Last Update
May 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.